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PERTUSSIS  TOXIN INHIB IT ION OF CHEMOTACTIC  
FACTOR- INDUCED CALCIUM MOBIL IZAT ION AND 
FUNCTION IN HUMAN POLYMORPHONUCLEAR 
LEUKOCYTES 
BY D. W. GOLDMAN, F.-H. CHANG, L. A. GIFFORD, E.J. GOETZL, AND 
H. R. BOURNE 
From the Howard Hughes Medical Institute, and the Division of Allergy and Immunology, 
Departments ofMedicine and Pharmacology, University of California Medical Center, San 
Francisco, California 94143 
The binding of lipid and peptide chemotactic factors to cell surface receptors 
on polymorphonuclear leukocytes (PMNL) l initiates a series of intracellular 
biochemical events that lead to increased chemokinetic and chemotactic migra- 
tion, aggregation, adherence, lysosomal degranulation, and production of super- 
oxide anion (1-3). The rapid stimulation, by chemotactic factors, of phospholipid 
and protein methylation (4-6), arachidonic acid release (4, 5, 7), phosphatidyl 
inositol turnover (8-10), internal calcium release and influx of extracellular 
calcium (1 1, 12), glucose flux (13), and membrane depolarization (14) suggests 
that these events are closely coupled to receptor occupancy, yet little is known 
about the transductional process. 
Modulation by guanine nucleotides of the affinity of receptors for N-formyl- 
methionyl peptides in membranes of human PMNL (15), and the activation, by 
N-formyl-methionyl-leucyl-phenylalanine (fMLP), of a GTPase activity in ho- 
mogenates of PMNL (16) suggested that a guanine nucleotide-binding protein 
may participate in the transduction of signals from occupied receptors. Hormon- 
ally stimulated activation and inhibition of adenylate cyclase are mediated by 
coupling proteins, termed Gs and Gi, respectively, which have similar subunit 
structures and amino acid compositions (17); the a subunit of each protein 
contains a guanine nucleotide-binding site. Cholera toxin-induced ADP-ribo- 
sylation of the o~ subunit of Gs stabilizes Gs in the active state, and results in 
persistent activation of adenylate cyclase (18-20). A bacterial toxin isolated from 
Bordetella pertussis imilarly catalyzes ADP-ribosylation of the a subunit of Gi, 
and, consequently, attenuates hormonal inhibition of adenylate cyclase activity 
(18, 19, 21). Although pertussis toxin treatment of rat mast cells does not alter 
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cyclic AMP (cAMP) levels (22), it blocks ligand-stimulated release of  histamine 
(23). That  pertussis toxin might be acting on a GTP-binding protein was 
suggested by the capacity of  stable analogs of  GTP  to promote histamine release 
(23-25). To  determine whether a pertussis toxin-sensitive GTP-binding protein 
is involved in the coupling of PMNL chemotactic factor receptors to functional 
activation, we assessed the effects of  pertussis toxin on binding of leukotriene B4 
(LTB4) to human PMNL and on chemotactic factor- induced increases in cyto- 
solic calcium concentration, chemotactic migration, and degranulation. 
Mater ia ls  and  Methods  
Materials. Hank's balanced salt solution without phenol red (HBSS) (University of 
California Cell Culture Facility, San Francisco, CA), diisopropylfluorophosphate (DFP), 
fMLP, n-butyl phthalate, 4-/3-phorbol-12-myristate-13-acetate (PMA), phenoiphthalein 
glucuronic acid, human albumin, lyophilized Micrococcus lysodeikticus (Sigma Chemical 
Co., St. Louis, MO), ovalbumin (OVA) (Miles Laboratories, Inc., Elkhart, IN), Ficoll- 
Paque, 6% (wt/vol) dextran 70 in normal saline (Pharmacia Fine Chemicals, Piscataway, 
N J), a-[3~P]-NAD (New England Nuclear, Boston, MA), 5, 6, 8, 9, 1 I, 12, 14, 15 (N)- 
[3H]-LTB4 (209 Ci/mmole), Quin 2/AM (Amersham Corp., Arlington Heights, IL), 
A23187 (Calbiochem-Behring, La Jolla, CA), cytochalasin B (Aldrich Chemical Co., 
Milwaukee, WI), Hydrofluor scintillation fluid (National Diagnostics, Inc., Somerville, NJ) 
and gel electrophoresis reagents (Bio-Rad, Richmond, CA) were obtained from the 
suppliers noted. Partially purified chc lotactic fragments of C5 (C5fr) were prepared 
from yeast-activated human serum, as described (26). Synthetic LTB4 was kindly supplied 
by J. Rokach of Merck Frosst Laboratories, Dorval, Canada. Purified pertussis toxin (27) 
was a gift from R. D. Sekura of the National Institute of Child Health and Human 
Development, Bethesda, MD. 
Preparation of Human PMNL and Treatment with Pertussis Toxin. Human PMNL were 
prepared as described (28) from sodium citrate-anticoagulated v nous blood of normal 
donors. Erythrocytes were removed by dextran sedimentation, followed by a 20-s hypo- 
tonic lysis in 20 vol of ice-cold distilled water. Isotonicity was restored by adding 0.6 M 
KC1. PMNL of >~96% purity were obtained by centrifugation of mixed leukocytes on 
FicolI-Paque cushions (29). The purified PMNL were suspended at 2 × 107 cells/ml in 
HBSS containing 0.1% (wt/vol) OVA and 10 mM Hepes (pH 7.3) (HBSS-OVA). 
2 × 10 v PMNL/ml of HBSS-OVA were incubated at 37°C with different concentrations 
of pertussis toxin for 2 h. Quin 2-containing PMNL were prepared by adding 20 #M 
diacetometboxyester of Quin 2 15 min before the end of incubation. The PMNL were 
then washed several times and resuspended in HBSS-OVA. Control PMNL were incubated 
for 2 h at 37°C without any additions. 
Measurement of Quin 2 Fluorescence. Chemotactic factor-induced changes in Quin 2 
fluorescence, a measure of changes in the cytosolic calcium concentration (30), was 
determined as previously described (31). 107 PMNL were suspended in 2 ml of fresh 
HBSS-OVA and incubated at 37°C in the dark for 15 min. The fluorescence signal was 
then recorded with a Perkin-Elmer model 640-40 spectrofluorimeter (Perkin-EImer, 
Mountain View, CA) equipped with a magnetic stirrer and a water-jacketed cuvette 
holder. The monochromators were set at 339 nm for excitation and 492 nm for emission. 
The maximum and minimum fluorescence signals were determined for each batch of 
PMNL after the addition of 20 ~1 of 1% (wt/vol) Triton X-100, followed by 40 ~l of 0.5 
M Tris and 0.5 M EGTA (pH 10). The autofluorescence from an equal number of PMNL 
without Quin 2 was subtracted from the Quin 2 fluorescence values. The corrected values 
were used to calculate the intracellular Ca +2 concentration, asdescribed (30). 
Measurement of[3H]LTB4 binding to PMNL. Replicate suspensions of 107 PMNL were 
incubated with 5 × 10 -14 mol [~H]LTB4 and different concentrations of nonradioactive 
LTB4 in a final volume of 0.5 ml for 40 rain in an ice-water bath. The PMNL were 
centrifuged through a phthalate-oil cushion, and the amounts of bound and free LTB4 
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were fit to either a one-site or two-site binding model by a method of weighted nonlinear 
least squares based on the LIGAND program (32) adapted for use on a Hewlett-Packard 
model 86B personal computer (Hewlett-Packard, Inc., Palo Alto, CA) (33). 
Measurement of Chemotactic Migration and Degranulation. Chemotactic migration was 
performed in modified Boyden chambers (Adaps, Inc., Dedham, MA) assembled with 
micropore filters of 3 um pore diameter (Sartorius, Gottingen, Federal Republic of 
Germany) (28, 33). PMNL were counted in 10 high-power microscope fields (hpf), 5 from 
each of duplicate filters, at a depth of 80-100 #m from the cel} source. The response is 
expressed as net PMNL/hpf, after subtraction of background migration of PMNL in 
control chambers lacking a stimulus. The altered chemotactic migration of PMNL 
pretreated with pertussis toxin is expressed as a percentage of the migration of replicate 
suspensions of PMNL preincubated in HBSS-OVA alone. 
The stimulation of release of/3-glucuronidase and lysozyme from PMNL was deter- 
mined in HBSS-OVA containing 5ug/ml of cytochalasin B. Each supernatant was assayed 
colorimetrically for/3-glucuronidase, as described (26), and for lysozyme by measuring 
the rate of digestion of Micrococcus lysodeikticus, and the resultant decrease in turbidity of 
the suspension (34). The amount of enzyme release is expressed as a percentage of the 
total amount of activity present in replicate suspensions of PMNL that had been disrupted 
by sonication on ice. The percentage of enzyme released in the absence of a stimulus was 
subtracted to determine the net percentage r lease• The altered release of enzymes by 
PMNL pretreated with pertussis toxin is presented as a percentage of the release by 
PMNL preincubated in HBSS-OVA alone. In separate xperiments, the simultaneous 
addition to PMNL of 100 ng/ml of pertussis toxin and a stimulus had no effect on the 
amount of/3-glucuronidase and lysozyme released by the stimulus alone, and the presence 
of up to 100 ng/ml of pertussis toxin with the respective substrates failed to alter the 
expression of activity of either enzyme. 
Pertussis Toxin Catalyzed ADP-ribosylation of PMNL Homogenates. PMNL were treated 
with 10 -4 M DFP in HBSS without calcium and magnesium at 37°C for 30 min (35). The 
PMNL were washed several times, resuspended at 108 cells/ml in ice cold 0.1 M sucrose 
containing 2 mM EDTA and 5 mM Tris-HCl (pH 7.2), and disrupted in a Dounce 
homogenizer with 120 strokes at 4°C. The homogenate was centrifuged at 800 g for 10 
min at 4°C and the supernatants were stored at -70°C. 
Pertussis toxin-catalyzed ADP-ribosylation of aliquots from the 800 g supernatants was 
• " 32  performed in 0.I M sucrose containing 10 ~M c~-[ P]NAD, 2.5 mM MgCl2, 1 mM ATP, 
10 mM thymidine, 1 mM dithiothreitol, and 5 mM Tris-HCl (pH 7.2), as previously 
described (19, 36). The reaction was terminated by the addition of 5 vol of Laemmli 
sample buffer (37). Protein was precipitated with 20% (wt/vol) of trichloroacetic a id, and 
the pellet was washed with anhydrous diethyl ether. The protein pellet was resuspended 
in Laemmli sample buffer, and analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (37). To quantitate incorporation of [32p] into the 41 kilo- 
dalton (kD) protein, the band was cut from dried gels and counted in a scintillation 
counter. 
Results 
Effects of Pertussis Toxin on Cytosolic Calcium. Quin 2-containing PMNL were 
used to monitor  changes in the cytosolic concentration of  intracellular calcium 
([Ca+2]in). Concentrations of LTB4 and fMLP > 1 and 10 nM, respectively, elicited 
a maximal increase of  1.8-2.5-fold in [Ca+2]in, f rom a resting value of  69-145 
nM to a peak value of  150-351 nM (range, n = 12) within 0.6-1.5 rain (Fig. 1). 
Pretreatment of  PMNL with 100 ng/ml of pertussis toxin for 2 h inhibited the 
LTB4- and fMLP-induced increases in [Ca+2]i~, by 98 + 2% (mean + SD; n = 4) 
without altering the baseline value for [Ca+2]i,, (Fig. 1). The  inhibition of LTB4- 
induced changes in [Ca+2]in by pertussis toxin was concentrat ion-dependent with 
half-maximal inhibition occurr ing at a concentration of  30 ng/ml  pertussis toxin. 
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FIGURE 1. Pertussis toxin inhibition of the chemotactic factor-induced increase in [Ca2+]in 
in human PMNL. The fluorescent signal from Quin 2-containing control PMNL was recorded 
for 3 rain before and 10 min after the addition of either 10 nM LTB4 or 100 nM fMLP. The 
fluorescent signal from Quin 2-containing PMNL that had been treated with 100 ng/ml 
pertussis toxin was recorded for 3 rain before and 3 rain after the addition of LTB4, then 100 
nM fMLP was added, and the fluorescent signal was recorded for an additional 3 min. 
In initial studies designed to assess the time course of pertussis toxin inhibition 
of the effects of LTB4 on [Ca+2]i., PMNL were pretreated with pertussis toxin 
for 30 and 90 rain before washing and adding 10 -7 M LTB4. Pertussis toxin at 
100, 300, and 1,000 ng/ml inhibited LTB4-induced increases in [Ca+2]i, by 
means of 5%, 6%, and 4% at 30 min, and 58%, 82%, and 80% at 90 min. A lag 
time of 30-60 min has also been observed for the effects of pertussis toxin on 
rat mast cells (22), pancreatic islet cells (38), and 3T3 cells (39), and is presumed 
to be required for binding of pertussis toxin and transport of the active subunit 
to the intracellular site of action (40). Pertussis toxin suppressed the increase in 
[Ca+~]i. at concentrations of LTB4 up to 3 × 10 -7 M, indicating that the toxin 
inhibits the increase in [Ca+2]in stimulated by both the high-affinity and low- 
affinity subsets of LTB4 receptors. 
Effect of Pertussis Toxin on Chemotaxis and Enzyme Release. The effects of 
pertussis toxin on chemotactic migration and lysosomal enzyme release were 
assessed to examine the possible role of increases in [Ca+2]i n in the activation of 
PMNL. Chemotaxis elicited by LTB4, C5fr, and fMLP, and the release of/3- 
glucuronidase elicited by LTB4 and fMLP in the presence of cytochalasin B were 
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inhibited by pertussis toxin with a concentration-dependence similar to that for 
inhibition of chemotactic factor-induced changes in [Ca+2]in (Figs. 2 and 3). Net 
release of 12.4 + 0.2% and 27.5 + 4.8% (mean _+ SD; n = 3) of lysozyme from 
control PMNL was elicited by 10 nM LTB4 and 1 #M fMLP, respectively. The 
release of lysozyme by the two chemotactic factors was decreased by means of 
88.7% and 87.6%, respectively, after pretreatment with 100 ng/ml of pertussis 
toxin. The inhibition by pertussis toxin was specific for chemotactic factor- 
induced release of lysosomal enzyme. Neither the release of/3-glucuronidase 
evoked by the calcium ionophore A23187 or by PMA, which stimulates a
secretory response without raising [Ca+2]in (41), was significantly affected by 
pertussis toxin (Fig. 3). Lysozyme secretion elicited from PMNL treated with 
100 ng/ml of pertussis toxin was 91.1% and 78.6% of the release licited from 
control PMNL in response to PMA and A23187, respectively. 
Effect of Pertussis Toxin on LTB4 Receptors. Incubation of PMNL with 100 
ng/ml pertussis toxin significantly reduced the number of high-affinity receptors 
for LTB4 by a mean of 61% on PMNL, and consistently induced a threefold 
increase in their affinity for LTB4, without affecting the number or agonist 
affinity of the low-affinity LTB4 receptors (Table I). This suggests that pertussis 
toxin acts at a step in the signal transduction process that is closely linked to the 
LTB4 receptor. 
ADP-ribosylation of PMNL Homogenates. Preactivated pertussis toxin specifi- 
cally catalyzes the transfer of [32p]-labeled ADP-ribose from [32p]NAD to a 41 
kD protein in PMNL homogenates (Fig. 4). The protein comigrates on SDS- 
PAGE with the ADP-ribosylated a subunit of Gi from human erythrocyte 
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FIGURE 2. 
• Leukotriene B 4 
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• f -Met-Leu-Phe 
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I I0  I00  1 ,000  
Pertussis Toxin (ng/rnl ) 
Concentration-dependence of inhibition of chemotaxis by pertussis toxin. Chem- 
otactic migration of 21 ± 5, 25 ± 8, and 20 ± 4 net PMNL per hpf was elicited from control 
leukocytes by 3 nM LTB4 (Q), 100 nM fMLP (.),  and a 1/20 dilution of C5fr (&), respectively. 
The stimulated response from pertussis toxin-treated PMNL is expressed as a percentage of
the response obtained from control PMNL. Each data point is the mean + SD of three or four 
experiments. 
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Concentration-dependence of inhibition of fl-glucuronidase r lease by pertussis 
toxin. Control PMNL released 18.5 _ 9.7%, 40.8 __+ 18.0%, 22.0 + 9.6%, and 66.7 + 13.7% 
of the total/3-glucuronidase ctivity in response to 3 nM LTB4 (O), 1 #M fMLP (ll), 10 ng/ml 
PMA (O), and 2 uM A23187 (I-I), respectively, in the presence of 5/~g/ml of cytochalasin B.
The stimulated response from pertussis toxin-treated PMNL is expressed as a percentage of
the response obtained from control PMNL. Each data point is the mean +_ SD of four 
experiments. 
TABLE I 
Binding of LTB4 to PMNL Treated With and Without Pertussis Toxin 
Treatment 
High-affinity receptors Low-affinity receptors 
Kd (× 10 -l°) Receptors/PMNL Kd (× 10 -7) Receptors/PMNL 
M M 
Control 9.6 - 4.9 9,900 + 3,100 3.5 _+ 2.6 440,000 + 190,000 
Pertussis toxin 3.3 + 2.9 3,900 + 900 2.0 + 0.7 440,000 +_ 200,000 
P 0.061 0.026 0.27 0.47 
PMNL were incubated without (control) or with 100 ng/ml pertussis toxin for 2 h. The 
binding of [3HILTB4 was then assessed at 0°C. The binding parameters epresent the mean 
_ SD obtained from three experiments. The P values were determined by a paired sample t- 
test. 
membranes. Homogenates prepared from control PMNL incorporated 2.2 pm 
of ADP-ribose per milligram of protein, while homogenates of PMNL treated 
with 100 ng/ml of pertussis toxin incorporated 0.9 pm of ADP-ribose per 
milligram of protein. Preincubation of PMNL with 300 ng/ml of pertussis toxin 
for 3 h did not further reduce the amount of [32p]-Iabeled ADP-ribose subse- 
quently incorporated into the homogenate. Increasing the amount of NAD in 
the reaction mixture and adding a second aliquot of [32p]NAD 15 min after 
initiating the ADP-ribosylation i cubation did not increase the amount of ADP- 
ribose incorporated; this suggested that the incubation conditions caused com- 
plete ADP-ribosylation of the 41 kD protein. Thus, only 59% of the 41 kD 
GOLDMAN ET AL. 151 
FIGURE 4. Pertussis toxin-catalyzed ADP-ribosylation of proteins of homogenates of PMNL. 
PMNL were incubated without (A) or with (B) 100 ng/ml pertussis toxin for 2 h. Homogenates 
~repared from treated PMNL were incubated with activated pertussis toxin and 10 #M a- 
[ P]NAD, and the ADP-ribosylated proteins were analyzed on SDS-PAGE. 
proteins in PMNL homogenates are accessible for pertussis toxin-stimulated 
ADP-ribosylation in intact PMNL. Pertussis toxin-catalyzed modification of 
these accessible sites is associated with inhibition of stimulated PMNL function. 
Discussion 
The possible involvement of a guanine nucleotide-binding protein in the 
signal transduction process initiated by occupancy of chemotactic factor eceptors 
in PMNL (15, 16), combined with the inhibition by pertussis toxin of calcium- 
dependent release of histamine in mast cells (23), suggested that pertussis toxin 
may inhibit the increase in [Ca+2]in stimulated by chemotactic factors in human 
PMNL. The use of Quin 2 to measure [Ca+2]in permitted a direct demonstration 
of the inhibitory effects of pertussis toxin on chemotactic factor-induced stimu- 
lation of [Ca+2]in (Fig. 1). The increase in [Ca+2]i n induced by LTB4 and fMLP in 
PMNL consists of two components, an increased influx of extracellular calcium, 
and calcium release from intracellular stores (11, 12). Human PMNL incubated 
in calcium-free media containing 5 mM EGTA will respond to LTB4 and fMLP 
with an increase in Quin 2 fluorescence, but the increase is only 10%-15% of 
that observed in the presence of extracellular calcium (D. W. Goldman, unpub- 
lished observation), suggesting that the inhibition of Quin 2 fluorescence hanges 
are in part due to the inhibition of calcium influx. Recent studies have shown 
that the influx of 45Ca+2 induced by fMLP in guinea pig neutrophils (42) and the 
changes in [Ca+2]in induced by fMLP and LTB4 in rabbit neutrophils (43) are 
inhibited by pertussis toxin. 
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Pertussis toxin inhibited chemotactic factor-induced [Ca+~]in creases, chem- 
otaxis, and lysosomal enzyme release, but not non-receptor-stimulated enzyme 
release (Figs. 2 and 3), demonstrating that pertussis toxin acts at an early stage 
in the signal transduction process. The decrease in high-affinity LTB4 receptor 
number induced by pertussis toxin (Table I) implies a direct link between the 
site of pertussis toxin action and the LTB4 receptor. Guanine nucleotides also 
decrease the number of high-affinity fMLP (15) and LTB4 (D. W. Goldman, 
unpublished observation) receptors on PMNL plasma membranes. That pertussis 
toxin may modify a guanine nucleotide-binding protein is suggested by the 
similar effects of guanine nucleotides and pertussis toxin on chemotactic factor 
receptors and on a2 adrenergic receptors. In neuroblastoma x glioma hybrid 
cell membranes (44) and in rat renal cortical membranes (45), a2 adrenergic 
receptor affinity for agonist binding is decreased, consistent with a redistribution 
of receptors between high- and low-affinity states. Pertussis toxin attenuated 
agonist-induced inhibition of adenylate cyclase, with a concomitant decrease in 
average affinity of agonist binding of ee2 adrenergic receptors. 
Reagents that increase cAMP levels in PMNL inhibit chemotaxis and lysosomal 
enzyme release (46). Pertussis toxin-catalyzed ADP-ribosylation of the a subunit 
of Gi uncouples adenylate cyclase from inhibition by 0~2 adrenergic agonists (18, 
19, 21, 44), with a resultant enhancement of cAMP levels in response to agonists 
that stimulate adenylate cyclase. However, pertussis toxin had no effect on cAMP 
levels in mast cells (22), and has been recently reported not to alter cAMP levels 
(42) or to substantially modify the fMLP-induced cAMP rise (47) in guinea pig 
neutrophils. This suggests that the inhibitory effects of pertussis toxin on PMNL 
function are not secondary to a change in cAMP content. 
A 41 kD protein, which comigrated with the oe subunit of Gi from human 
erythrocyte membranes on SDS-PAGE, was ADP-ribosylated by pertussis toxin 
in PMNL homogenates (Fig. 4). Although only 59% of the total sites available 
for ADP-ribosylation i the homogenates were accessible in intact PMNL, PMNL 
function was almost completely inhibited. Several studies (48) have identified 
subpopulations of PMNL that are functionally nonresponsive to chemotactic 
factors. If the 41 kD protein were accessible for ADP-ribosylation by pertussis 
toxin only in responding PMNL, then ADP-ribosylation of only a fraction of the 
total sites detected in homogenates could account for the almost complete 
inhibition of PMNL function. In that case, the defect in the nonresponding 
PMNL subpopulation might be caused by uncoupling of the 41 kD protein from 
the chemotactic factor receptors; the uncoupling phenomenon could reflect he 
same biochemical defect hat makes the protein inaccessible to pertussis toxin in 
intact PMNL. Alternatively, all the PMNL may be sensitive to pertussis toxin, 
but a fraction of the 41 kD protein may be sequestered in an intracellular 
compartment that is not accessible to pertussis toxin, or is not involved in the 
signal transduction process. 
Summary 
Chemotactic factors stimulate a rapid increase in the cytosolic oncentration 
of intracellular calcium ions ([Ca2+]in) in human polymorphonuclear leukocytes 
(PMNL), which may be an event hat is critical to the expression of chemotaxis 
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and other PMNL functions. Treatment of PMNL with pertussis toxin catalyzes 
ADP-ribosylation of a protein similar or identical to the inhibiting regulatory 
protein of adenylate cyclase, Gi, and suppresses the increase in [Ca2+]in elicited 
by leukotriene B4 (LTB4) and formyl-methionyMeucyl-phenylalanine. Chemotac- 
tic migration and lysosomal enzyme release licited by chemotactic factors were 
inhibited by pertussis toxin with a concentration-dependence similar to that for 
inhibition of  the increase in [Cae+]in, without an effect on lysosomal enzyme 
release induced by the ionophore A23187 and phorbol myristate acetate. Acti- 
vated pertussis toxin catalyzed the [3zP]ADP-ribosylation of a 41 kD protein in 
homogenates of PMNL. The extent of  [32P]ADP-ribosylation f this protein was 
reduced 59% by pretreatment of intact PMNL with pertussis toxin. Pertussis 
toxin selectively decreased the number of high-affinity receptors for LTB4 on 
PMNL by 60% without altering the number or binding properties of the low- 
affinity subset of receptors. Pertussis toxin modification of a membrane protein 
of PMNL analogous to Gi thus simultaneously alters chemotactic receptors and 
attenuates the changes in cytosolic calcium concentration and PMNL function 
caused by chemotactic factors. 
Received for publication 7January 1985 and in revised form 27 March 1985. 
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